Intra-Cellular Therapies (ITCI) EV US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EV, bln rub | ? | 1 609 | 22 541 | -572 | -481 | 7 629 | 12 616 | ||
| Changes by years, y/y, % | -5% | +1 301% | -103% | -16% | -1 686% | +35.1% | |||
Intra-Cellular Therapies. EV, bln rub
Intra-Cellular Therapies. EV, changes, %
Intra-Cellular Therapies (ITCI) EV US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| EV, bln rub | ? | -481 | -461 | -1 006 | 6 750 | 7 629 | 12 616 | |
| Changes by years, y/y, % | -16% | -110% | -118% | -1 519% | -1 686% | |||
| Changes by quarters, q/q, % | +1% | -4% | +118% | -771% | +13% | |||